Home » WATSON PHARMACEUTICALS TO CONSOLIDATE SOLID DOSAGE MANUFACTURING FACILITIES
WATSON PHARMACEUTICALS TO CONSOLIDATE SOLID DOSAGE MANUFACTURING FACILITIES
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading
specialty pharmaceutical company, today announced its plan to consolidate certain
of its solid dosage manufacturing operations, as part of an ongoing effort to
optimize the Company's manufacturing operations. Over the last several years,
Watson has made significant improvements and enhancements to its solid dosage
manufacturing facilities, creating the opportunity for its Carmel, NY and Corona,
CA sites to absorb additional production volume.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May